While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to ...
Facing declining valuations and funding challenges, public biotechs like bluebird bio are going private to restructure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback